import{_ as e,o as a,c as i,O as o}from"./chunks/framework.9482e208.js";const b=JSON.parse('{"title":"§ 22.1-274.2 Possession and administration of inhaled asthma medications and epinephrine by certain students or school board employees.","description":"","frontmatter":{},"headers":[],"relativePath":"vacode/22.1-274.2.md","filePath":"vacode/22.1-274.2.md"}'),t={name:"vacode/22.1-274.2.md"},n=o('<h1 id="§-22-1-274-2-possession-and-administration-of-inhaled-asthma-medications-and-epinephrine-by-certain-students-or-school-board-employees" tabindex="-1">§ 22.1-274.2 Possession and administration of inhaled asthma medications and epinephrine by certain students or school board employees. <a class="header-anchor" href="#§-22-1-274-2-possession-and-administration-of-inhaled-asthma-medications-and-epinephrine-by-certain-students-or-school-board-employees" aria-label="Permalink to &quot;§ 22.1-274.2 Possession and administration of inhaled asthma medications and epinephrine by certain students or school board employees.&quot;">​</a></h1><p>A. Local school boards shall develop and implement policies permitting a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, during the school day, at school-sponsored activities, or while on a school bus or other school property. Such policies shall include, but not be limited to, provisions for:</p><ol><li><p>Written consent of the parent, as defined in § <a href="/vacode/22.1-1/">22.1-1</a>, of a student with a diagnosis of asthma or anaphylaxis, or both, that the student may self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.</p></li><li><p>Written notice from the student&#39;s primary care provider or medical specialist, or a licensed physician or licensed nurse practitioner that (i) identifies the student; (ii) states that the student has a diagnosis of asthma or anaphylaxis, or both, and has approval to self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, that have been prescribed or authorized for the student; (iii) specifies the name and dosage of the medication, the frequency in which it is to be administered and certain circumstances which may warrant the use of inhaled asthma medications or auto-injectable epinephrine, such as before exercising or engaging in physical activity to prevent the onset of asthma symptoms or to alleviate asthma symptoms after the onset of an asthma episode; and (iv) attests to the student&#39;s demonstrated ability to safely and effectively self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.</p></li><li><p>Development of an individualized health care plan, including emergency procedures for any life-threatening conditions.</p></li><li><p>Consultation with the student&#39;s parent before any limitations or restrictions are imposed upon a student&#39;s possession and self-administration of inhaled asthma medications and auto-injectable epinephrine, and before the permission to possess and self-administer inhaled asthma medications and auto-injectable epinephrine at any point during the school year is revoked.</p></li><li><p>Self-administration of inhaled asthma medications and auto-injectable epinephrine to be consistent with the purposes of the Virginia School Health Guidelines and the Guidelines for Specialized Health Care Procedure Manuals, which are jointly issued by the Department of Education and the Department of Health.</p></li><li><p>Disclosure or dissemination of information pertaining to the health condition of a student to school board employees to comply with §§ <a href="/vacode/22.1-287/">22.1-287</a> and <a href="/vacode/22.1-289/">22.1-289</a> and the federal Family Education Rights and Privacy Act of 1974, as amended, 20 U.S.C. § 1232g, which govern the disclosure and dissemination of information contained in student scholastic records.</p></li></ol><p>B. The permission granted a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, shall be effective for one school year. Permission to possess and self-administer such medications shall be renewed annually. For the purposes of this section, &quot;one school year&quot; means 365 calendar days.</p><p>C. Local school boards shall adopt and implement policies for the possession and administration of epinephrine in every school, to be administered by any school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine to any student believed to be having an anaphylactic reaction. Such policies shall require that at least one school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine has the means to access at all times during regular school hours any such epinephrine that is stored in a locked or otherwise generally inaccessible container or area.</p><p>D. Each local school board shall adopt and implement policies for the possession and administration of undesignated stock albuterol inhalers and valved holding chambers in every public school in the local school division, to be administered by any school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by the local health director and trained in the administration of albuterol inhalers and valved holding chambers for any student believed in good faith to be in need of such medication.</p><p>2000, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?001+ful+CHAP0871" target="_blank" rel="noreferrer">871</a>; 2005, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?051+ful+CHAP0785" target="_blank" rel="noreferrer">785</a>; 2012, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?121+ful+CHAP0787" target="_blank" rel="noreferrer">787</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?121+ful+CHAP0833" target="_blank" rel="noreferrer">833</a>; 2013, cc. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?131+ful+CHAP0336" target="_blank" rel="noreferrer">336</a>, <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?131+ful+CHAP0617" target="_blank" rel="noreferrer">617</a>; 2020, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?201+ful+CHAP0476" target="_blank" rel="noreferrer">476</a>; 2021, Sp. Sess. I, c. <a href="http://lis.virginia.gov/cgi-bin/legp604.exe?212+ful+CHAP0508" target="_blank" rel="noreferrer">508</a>.</p>',7),s=[n];function r(l,h,d,c,p,m){return a(),i("div",null,s)}const u=e(t,[["render",r]]);export{b as __pageData,u as default};
